BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25624991)

  • 1. Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma.
    Shibata C; Otsuka M; Kishikawa T; Ohno M; Yoshikawa T; Takata A; Koike K
    World J Hepatol; 2015 Jan; 7(1):1-6. PubMed ID: 25624991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma.
    Lim LJ; Wong SYS; Huang F; Lim S; Chong SS; Ooi LL; Kon OL; Lee CG
    Cancer Res; 2019 Oct; 79(20):5131-5139. PubMed ID: 31337653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
    George J; Patel T
    Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
    J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma.
    Zhu HR; Yu XN; Zhang GC; Shi X; Bilegsaikhan E; Guo HY; Liu LL; Cai Y; Song GQ; Liu TT; Dong L; Janssen HLA; Weng SQ; Wu J; Shen XZ; Zhu JM
    Int J Mol Med; 2019 Nov; 44(5):1844-1854. PubMed ID: 31485608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.
    Bao H; Su H
    Biomed Res Int; 2017; 2017():6049480. PubMed ID: 28835896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs.
    Tran DDH; Kessler C; Niehus SE; Mahnkopf M; Koch A; Tamura T
    Oncogene; 2018 Jan; 37(1):75-85. PubMed ID: 28869604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
    Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
    Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects of Noncoding RNAs in Hepatocellular Carcinoma.
    Zhou H; Xu Q; Ni C; Ye S; Xu X; Hu X; Jiang J; Hong Y; Huang D; Yang L
    Biomed Res Int; 2018; 2018():6579436. PubMed ID: 30148169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.
    Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF
    Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MicroRNA and Long Noncoding RNA as Biomarkers of Cardiovascular Diseases.
    Shi Q; Yang X
    J Cell Physiol; 2016 Apr; 231(4):751-5. PubMed ID: 26308238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review.
    Morishita A; Oura K; Tadokoro T; Fujita K; Tani J; Masaki T
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33572780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma.
    Mehra M; Chauhan R
    Biomark Cancer; 2017; 9():1179299X17737301. PubMed ID: 29147078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Wang J; Pu J; Yao T; Lu X; Deng Y
    J Cell Physiol; 2019 Jun; 234(6):8709-8716. PubMed ID: 30417366
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.